Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure solutions remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/skyren-daos-presale-gains-traction-as-investors-seek-stability-following-2-1b-market-liquidation/